Researchers identify an unexpected genetic pathway behind excess hydrogen sulfide — offering fresh insight into infection risk, inflammation and potential new therapies.

NIH-funded study finds bone injuries worsen with age in Down syndrome, paving the way for targeted treatments that could improve quality of life.